Monitoring Drug-Induced Brain Activity Changes with Functional Ultrasound Imaging and Convolutional Neural Networks
Authors:
Jared Deighton,
Shan Zhong,
Kofi Agyeman,
Wooseong Choi,
Charles Liu,
Darrin Lee,
Vasileios Maroulas,
Vasileios Christopoulos
Abstract:
Functional ultrasound imaging (fUSI) is a cutting-edge technology that measures changes in cerebral blood volume (CBV) by detecting backscattered echoes from red blood cells moving within its field of view (FOV). It offers high spatiotemporal resolution and sensitivity, allowing for detailed visualization of cerebral blood flow dynamics. While fUSI has been utilized in preclinical drug development…
▽ More
Functional ultrasound imaging (fUSI) is a cutting-edge technology that measures changes in cerebral blood volume (CBV) by detecting backscattered echoes from red blood cells moving within its field of view (FOV). It offers high spatiotemporal resolution and sensitivity, allowing for detailed visualization of cerebral blood flow dynamics. While fUSI has been utilized in preclinical drug development studies to explore the mechanisms of action of various drugs targeting the central nervous system, many of these studies have primarily focused on predetermined regions of interest (ROIs). This focus may overlook relevant brain activity outside these specific areas, which could influence the results. To address this limitation, we combined convolutional neural networks (CNNs) with fUSI to comprehensively understand the pharmacokinetic process of Dizocilpine, also known as MK-801, a drug that blocks the N-Methyl-D-aspartate (NMDA) receptor in the central nervous system. CNN and class activation mapping (CAM) revealed the spatiotemporal effects of MK-801, which originated in the cortex and propagated to the hippocampus, demonstrating the ability to detect dynamic drug effects over time. Additionally, CNN and CAM assessed the impact of anesthesia on the spatiotemporal hemodynamics of the brain, revealing no distinct patterns between early and late stages. The integration of fUSI and CNN provides a powerful tool to gain insights into the spatiotemporal dynamics of drug action in the brain. This combination enables a comprehensive and unbiased assessment of drug effects on brain function, potentially accelerating the development of new therapies in neuropharmacological studies.
△ Less
Submitted 12 October, 2024;
originally announced October 2024.
Molecule Design by Latent Prompt Transformer
Authors:
Deqian Kong,
Yuhao Huang,
Jianwen Xie,
Edouardo Honig,
Ming Xu,
Shuanghong Xue,
Pei Lin,
Sanping Zhou,
Sheng Zhong,
Nanning Zheng,
Ying Nian Wu
Abstract:
This work explores the challenging problem of molecule design by framing it as a conditional generative modeling task, where target biological properties or desired chemical constraints serve as conditioning variables. We propose the Latent Prompt Transformer (LPT), a novel generative model comprising three components: (1) a latent vector with a learnable prior distribution modeled by a neural tra…
▽ More
This work explores the challenging problem of molecule design by framing it as a conditional generative modeling task, where target biological properties or desired chemical constraints serve as conditioning variables. We propose the Latent Prompt Transformer (LPT), a novel generative model comprising three components: (1) a latent vector with a learnable prior distribution modeled by a neural transformation of Gaussian white noise; (2) a molecule generation model based on a causal Transformer, which uses the latent vector as a prompt; and (3) a property prediction model that predicts a molecule's target properties and/or constraint values using the latent prompt. LPT can be learned by maximum likelihood estimation on molecule-property pairs. During property optimization, the latent prompt is inferred from target properties and constraints through posterior sampling and then used to guide the autoregressive molecule generation. After initial training on existing molecules and their properties, we adopt an online learning algorithm to progressively shift the model distribution towards regions that support desired target properties. Experiments demonstrate that LPT not only effectively discovers useful molecules across single-objective, multi-objective, and structure-constrained optimization tasks, but also exhibits strong sample efficiency.
△ Less
Submitted 31 October, 2024; v1 submitted 26 February, 2024;
originally announced February 2024.
